The European Commission has granted Marketing Authorisation to Janssen for a new Ebola vaccine, developed in partnership with the University of Oxford.  - The two-dose Ebola vaccine regimen, Zabdeno (Ad26.ZEBOV) and Mvabea (MVA-BN-Filo), has been developed by the Janssen Pharmaceutical Companies of Johnson & Johnson for the prevention of Ebola Virus Disease caused by the Zaire Ebola virus species.

In March 2020, the RECOVERY (Randomised Evaluation of COVid-19 thERapY) trial was established as a randomised clinical trial to test a range of potential treatments for COVID-19, including low-dose dexamethasone (a steroid treatment). Over 11,500 patients have been enrolled from over 175 NHS hospitals in the UK.

In light of the traumatic effect of the killing of George Floyd, and the global focus it has brought to communities and organisations to take further action on racism, the University is reaffirming its unequivocal abhorrence of and opposition to racism against Black and Minority Ethnic people and discrimination in all its forms. We are committed to addressing systemic racism wherever it may be found, including within our own community.

Scientists at the Universities of Oxford, Exeter, Yunnan and Bristol and have discovered the oldest fossil of the group of animals that contains earthworms, leeches, ragworms and lugworms. This discovery pushes the origin of living groups of these worms (polychaetes) back tens of millions of years, demonstrating that they played an important part in the earliest animal ecosystems.

UK Research and Innovation, Cancer Research UK and industry are investing more than £11 million in an Oxford-led artificial intelligence (AI) research programme to improve the diagnosis of lung cancer and other thoracic diseases. 

Parents/carers of children aged 4-10 years of age reported that over a one-month period in lockdown, they saw increases in their child's emotional difficulties, such as feeling unhappy, worried, being clingy and experiencing physical symptoms associated with worry, according to early results from the Co-SPACE study, asking parents and carers about their children's mental health through the COVID-19 crisis.

The University of Oxford-led National Consortium of Intelligent Medical Imaging (NCIMI) in the UK is collaborating with GE Healthcare to develop and test algorithms to aid in the diagnosis and management of COVID-19 pneumonia.

New research from The George Institute for Global Health at the University of Oxford has found significant gender bias in research authorship relating to COVID-19, which means that women's views are not equally shaping the response to the pandemic.